Zurich Cantonal Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Sell
39,984
-7,660
-16% -$522K 0.01% 901
2026
Q1
$3.08M Buy
47,644
+12,139
+34% +$856K 0.01% 821
2025
Q4
$2.39M Sell
35,505
-2,227
-6% -$150K 0.01% 880
2025
Q3
$2.77M Buy
37,732
+1,651
+5% +$110K 0.01% 786
2025
Q2
$1.88M Buy
36,081
+4,013
+13% +$228K ﹤0.01% 895
2025
Q1
$2.05M Sell
32,068
-804
-2% -$46.7K 0.01% 811
2024
Q4
$1.57M Buy
32,872
+2,241
+7% +$115K ﹤0.01% 967
2024
Q3
$1.75M Buy
30,631
+1,586
+5% +$90.9K 0.01% 845
2024
Q2
$1.52M Buy
29,045
+2,740
+10% +$120K ﹤0.01% 851
2024
Q1
$1.07M Sell
26,305
-1,066
-4% -$40K ﹤0.01% 1033
2023
Q4
$1.01M Buy
27,371
+504
+2% +$19K ﹤0.01% 1061
2023
Q3
$1.03M Buy
26,867
+3,560
+15% +$146K ﹤0.01% 953
2023
Q2
$841K Buy
23,307
+2,404
+12% +$82K ﹤0.01% 1027
2023
Q1
$798K Buy
20,903
+697
+3% +$32.7K ﹤0.01% 1012
2022
Q4
$1.15M Buy
20,206
+1,625
+9% +$83.2K 0.01% 821
2022
Q3
$735K Buy
18,581
+1,847
+11% +$81.6K ﹤0.01% 969
2022
Q2
$736K Sell
16,734
-2,085
-11% -$90.2K ﹤0.01% 991
2022
Q1
$751K Sell
18,819
-525
-3% -$18.7K ﹤0.01% 1075
2021
Q4
$778K Buy
19,344
+4,951
+34% +$185K ﹤0.01% 1148
2021
Q3
$586K Buy
14,393
+25
+0.2% +$1.04K ﹤0.01% 1202
2021
Q2
$652K Buy
14,368
+123
+0.9% +$5.44K ﹤0.01% 1069
2021
Q1
$594K Sell
14,245
-2,667
-16% -$122K ﹤0.01% 1115
2020
Q4
$722K Buy
16,912
+968
+6% +$34.8K ﹤0.01% 1091
2020
Q3
$419K Hold
15,944
﹤0.01% 1168
2020
Q2
$427K Buy
15,944
+4,797
+43% +$108K ﹤0.01% 1090
2020
Q1
$201K Buy
11,147
+1,111
+11% +$21.1K ﹤0.01% 1233
2019
Q4
$178K Buy
10,036
+1,911
+24% +$33.1K ﹤0.01% 1407
2019
Q3
$126K Hold
8,125
﹤0.01% 1488
2019
Q2
$140K Hold
8,125
﹤0.01% 1433
2019
Q1
$131K Sell
8,125
-1,666
-17% -$27K ﹤0.01% 1417
2018
Q4
$143K Buy
9,791
+2,430
+33% +$38.8K ﹤0.01% 1389
2018
Q3
$134K Hold
7,361
﹤0.01% 1542
2018
Q2
$124K Hold
7,361
﹤0.01% 1538
2018
Q1
$144K Hold
7,361
﹤0.01% 1396
2017
Q4
$149K Buy
7,361
+2,256
+44% +$41.5K ﹤0.01% 1355
2017
Q3
$89K Hold
5,105
﹤0.01% 1463
2017
Q2
$65K Buy
5,105
+696
+16% +$9.3K ﹤0.01% 1601
2017
Q1
$57K Hold
4,409
﹤0.01% 1667
2016
Q4
$44K Hold
4,409
﹤0.01% 1774
2016
Q3
$53K Buy
4,409
+593
+16% +$6.06K ﹤0.01% 1598
2016
Q2
$33K Hold
3,816
﹤0.01% 1740
2016
Q1
$36K Hold
3,816
﹤0.01% 1599
2015
Q4
$66K Buy
3,816
+2,713
+246% +$43.2K ﹤0.01% 1302
2015
Q3
$15K Buy
1,103
+639
+138% +$12.8K ﹤0.01% 1633
2015
Q2
$10K Hold
464
﹤0.01% 1379
2015
Q1
$7K Buy
+464
New +$6.69K ﹤0.01% 1605
2014
Q3
Sell
-60,000
Closed -$593K 976
2014
Q2
$593K Buy
60,000
+20,000
+50% +$170K 0.02% 683
2014
Q1
$508K Hold
40,000
0.02% 693
2013
Q4
$600K Hold
40,000
0.02% 590
2013
Q3
$442K Sell
40,000
-50,000
-56% -$417K 0.02% 636
2013
Q2
$715K Buy
+90,000
New +$573K 0.03% 500

Other funds holding HALO

Zurich Cantonal Bank's HALO Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Halozyme (HALO) stake by 16% in Q2 2026, selling an estimated $522K and leaving 39,984 shares worth $3.13M. The position accounts for 0.01% of the portfolio, ranked #901.

Zurich Cantonal Bank first reported a position in HALO in Q2 2013 and has held it in 51 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Zurich Cantonal Bank held 39,984 shares of Halozyme worth $3.13M as of Q2 2026.
  • Zurich Cantonal Bank sold 7,660 Halozyme shares in Q2 2026, an estimated $522K.
  • Halozyme made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #901 holding.
  • Zurich Cantonal Bank first reported a position in Halozyme in Q2 2013 and has held it in 51 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.